市場調査レポート

商品コード

1800893

電気生理学デバイス市場レポート：製品、適応症、エンドユーザー、地域別、2025年～2033年

Electrophysiology Devices Market Report by Product, Indication (Atrial Fibrillation, Supraventricular Tachycardia, Atrioventricular Nodal Re-entry Tachycardia, Wolff-Parkinson-White Syndrome, Bradycardia, and Other), End User, and Region 2025-2033

出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 148 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 2,999 447,600円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペースト、印刷はできません。

PDF & Excel (5 User License)

USD 3,999 596,850円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストはできませんが、印刷は5部まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,999 746,100円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストは可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=149.25円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の電気生理学デバイスの市場規模は2024年に67億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに129億米ドルに達し、2025年から2033年にかけて7.58%の成長率（CAGR）を示すと予測しています。不整脈症例の増加、技術の進歩、低侵襲手技の需要拡大、医療費の増加、外来治療環境の拡大、有利な償還政策、早期診断に対する意識の高まり、医療機器への人工知能（AI）の統合などが市場成長を促進する要因となっています。

電気生理学デバイス市場動向：

心臓不整脈の有病率の上昇

心房細動（AF）やその他の様々な悪性疾患などの心臓不整脈の有病率の増加が市場成長の原動力となっています。業界レポートによると、心房細動（AF）は心臓の電気的または信号/フラッター問題として知られ、米国では約270万人が罹患しています。心房細動は脳卒中や心不全の最も一般的な原因であり、医療サービスに対する負担が増大しています。また、技術の進歩や可処分所得の増加により、患者の不整脈に対する意識が高まり、早期診断・早期治療が望まれています。

電気生理学デバイスにおける技術の進歩

電気生理学デバイス市場の成長は、主に急速な技術進歩によって支えられています。3Dマッピングシステムやその他の技術革新により、循環器専門医は心臓の電気活動の特定モデルを設計できるようになり、不整脈を患う患者の診断や治療が向上しています。さらに、カテーテルアブレーション技術の向上は、手技のリスクを軽減し、患者の回復時間を最小限に抑え、成功率を高めるのに役立っています。これに伴い、電気生理学におけるロボット支援システムの使用もまた、手技中の精度と制御を向上させており、市場の成長を大幅に後押ししています。

低侵襲手技の成長

低侵襲（MI）電気生理学的手技は回復時間、入院期間、手技リスクを軽減できるため、患者の治療に大きな需要をもたらしています。不整脈の治療に用いられるカテーテルアブレーションなどの処置は、標準的な手術に代わる、より外傷の少ない選択肢を提供します。これにより、さらに正確な診断が可能になり、患者への手術のコストや負担を減らしながら治療結果を高めることができます。これとは別に、イメージングとマッピング技術の開発は、MI介入をより面倒なものにせず、市場の成長を促進しています。

治療機器
- 主な種類
  - 植込み型除細動器（ICD）
  - 自動体外式除細動器（AED）
  - ペースメーカー
  - CRT-P
  - CRT-D
  - カテーテル
  - その他
診断装置
- 主な種類
  - ホルター心電図モニタリング装置
  - 診断用電気生理学カテーテル
  - 心電図（ECG）
  - EPマッピングおよびイメージングシステム
  - 挿入型心臓モニター（ICM）
  - その他

第7章市場内訳：適応症別

心房細動（AF）
上室性頻拍
房室結節リエントリー性頻拍（AVNRT）
ウォルフ・パーキンソン・ホワイト症候群（WPW）
徐脈
その他

第8章市場内訳：エンドユーザー別

病院
診断センター
その他

第9章市場内訳：地域別

北米
- 米国
- カナダ
アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
ラテンアメリカ
- ブラジル
- メキシコ
- その他
中東・アフリカ

第10章 SWOT分析

第11章バリューチェーン分析

第12章ポーターのファイブフォース分析

第13章価格分析

第14章競合情勢

市場構造
主要企業
主要企業のプロファイル
- Biosense Webster Inc.（Johnson & Johnson）
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Cardiofocus Inc.
- Koninklijke Philips N.V.
- Medtronic Inc.
- MicroPort Scientific Corporation
- Molecular Devices LLC（Danaher Corporation）
- Nihon Kohden Corporation
- Siemens Healthcare GmbH
- Stereotaxis Inc.

図表

List of Figures

Figure 1: Global: Electrophysiology Devices Market: Major Drivers and Challenges
Figure 2: Global: Electrophysiology Devices Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Electrophysiology Devices Market: Breakup by Product (in %), 2024
Figure 4: Global: Electrophysiology Devices Market: Breakup by Indication (in %), 2024
Figure 5: Global: Electrophysiology Devices Market: Breakup by End User (in %), 2024
Figure 6: Global: Electrophysiology Devices Market: Breakup by Region (in %), 2024
Figure 7: Global: Electrophysiology Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 8: Global: Electrophysiology Devices (Treatment Devices) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Electrophysiology Devices (Treatment Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Electrophysiology Devices (Diagnostic Devices) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Electrophysiology Devices (Diagnostic Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Electrophysiology Devices (Atrial Fibrillation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Electrophysiology Devices (Atrial Fibrillation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Electrophysiology Devices (Supraventricular Tachycardia) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Electrophysiology Devices (Supraventricular Tachycardia) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Electrophysiology Devices (Atrioventricular Nodal Re-entry Tachycardia) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Electrophysiology Devices (Atrioventricular Nodal Re-entry Tachycardia) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Electrophysiology Devices (Wolff-Parkinson-White Syndrome) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Electrophysiology Devices (Wolff-Parkinson-White Syndrome) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Electrophysiology Devices (Bradycardia) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Electrophysiology Devices (Bradycardia) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Electrophysiology Devices (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Electrophysiology Devices (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Electrophysiology Devices (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Electrophysiology Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Electrophysiology Devices (Diagnostic Centers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Electrophysiology Devices (Diagnostic Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Electrophysiology Devices (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Electrophysiology Devices (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: North America: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: North America: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: United States: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: United States: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Canada: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Canada: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Asia Pacific: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Asia Pacific: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: China: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: China: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Japan: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: Japan: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: India: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: India: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: South Korea: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: South Korea: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Australia: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Australia: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Indonesia: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Indonesia: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Others: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Others: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Europe: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Europe: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Germany: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Germany: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: France: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: France: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: United Kingdom: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: United Kingdom: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Italy: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Italy: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Spain: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Spain: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Russia: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Russia: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Others: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Others: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Latin America: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Latin America: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Brazil: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Brazil: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Mexico: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Mexico: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Others: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Others: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Middle East and Africa: Electrophysiology Devices Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Middle East and Africa: Electrophysiology Devices Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Global: Electrophysiology Devices Industry: SWOT Analysis
Figure 79: Global: Electrophysiology Devices Industry: Value Chain Analysis
Figure 80: Global: Electrophysiology Devices Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Electrophysiology Devices Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Electrophysiology Devices Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 3: Global: Electrophysiology Devices Market Forecast: Breakup by Indication (in Million USD), 2025-2033
Table 4: Global: Electrophysiology Devices Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 5: Global: Electrophysiology Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Electrophysiology Devices Market: Competitive Structure
Table 7: Global: Electrophysiology Devices Market: Key Players

Product Code: SR112025A2620

The global electrophysiology devices market size reached USD 6.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 12.9 Billion by 2033, exhibiting a growth rate (CAGR) of 7.58% during 2025-2033. Rising cardiac arrhythmia cases, technological advancements, growing demand for minimally invasive procedures, increasing healthcare expenditure, expanding outpatient care settings, favorable reimbursement policies, escalating awareness of early diagnosis, and the integration of artificial intelligence (AI) in medical devices are some of the factors driving the market growth.

Electrophysiology Devices Market Trends:

Rising Prevalence of Cardiac Arrhythmias

Increasing prevalence of cardiac arrhythmias such as atrial fibrillation (AF) and various other malignant are driving the market growth. According to the industry reports, atrial fibrillation (AF), known as the electrical or signaling/flutter problem in the heart, is affecting almost 2.7 million people in United States. AF is the most common cause of strokes and heart failure, which is creating a growing burden on health services. In addition, expanding technological advancements and disposable income has boosted awareness about arrhythmias among patients, due to which they prefer early diagnosis and treatment.

Technological Advancements in Electrophysiology Devices

The growth of the electrophysiology devices market is primarily bolstered by the rapid technological advancements. 3D mapping systems and other innovations enable cardiologists to design specified models of the heart's electrical activity, which improves diagnosis and treatment for patients suffering with arrhythmias. Additionally, the improvements in catheter ablation technologies helps reduce procedural risks, while minimizing patient recovery times and increasing success rates. In line with this, the use of robotic-assisted systems in electrophysiology has also improved the precision and control during procedures, which is providing a considerable boost to the market growth.

Growth of Minimally Invasive Procedures

Minimally invasive (MI) electrophysiology procedures can reduce recovery times, hospital stays, and procedural risks, which is why they are witnessing a considerable demand for the treatment of patients. Procedures such as catheter ablation, which are used to treat arrhythmias, provide a less traumatic alternative to the standard surgeries. This further enables an accurate diagnosis and enhances the results of treatment at a reduced cost and strain of surgeries on patients. Apart from this, the development of imaging and mapping technologies, in turn, has made MI interventions less cumbersome, which is facilitating the market growth.

Electrophysiology Devices Market Segmentation:

Breakup by Product:

Treatment Devices
- Implantable Cardioverter Defibrillators (ICDs)
- Automated External Defibrillators (AEDs)
- Pacemakers
- CRT-P
- CRT-D
- Catheters
- Others
Diagnostic Devices
- Holter Monitoring Devices
- Diagnostic Electrophysiology Catheters
- Electrocardiograph (ECG)
- EP Mapping & Imaging Systems
- Insertable Cardiac Monitors (ICM)
- Others

Diagnostic devices accounts for the majority of the market share

The diagnostic devices segment is driven by the increasing prevalence of cardiovascular diseases, particularly arrhythmias, which require precise diagnosis for effective treatment. Technological advancements, such as improved electrocardiographs (ECGs) and EP mapping systems, are enhancing diagnostic accuracy, leading to wider adoption of these devices. Additionally, the growing awareness of early detection and prevention of heart conditions is boosting demand for diagnostic tools like Holter monitors and insertable cardiac monitors (ICMs). Healthcare providers are increasingly relying on these devices for continuous monitoring and accurate data collection, which improves patient outcomes. The rise in minimally invasive diagnostic procedures, which offer quicker recovery times and reduce the need for hospital stays, is further contributing to the segment's growth.

Breakup by Indication:

Atrial Fibrillation (AF)
Supraventricular Tachycardia
Atrioventricular Nodal Re-entry Tachycardia (AVNRT)
Wolff-Parkinson-White Syndrome (WPW)
Bradycardia
Other

Atrial fibrillation (AF) holds the largest share of the industry

The atrial fibrillation (AF) segment is driven by the increasing global prevalence of AF, particularly among aging populations, which is a leading cause of stroke and heart failure. As awareness about AF grows, there is a rising demand for early diagnosis and effective treatment, prompting healthcare providers to invest in advanced electrophysiology devices. Technological advancements in diagnostic tools, such as 3D mapping systems and catheter ablation technologies, have improved the accuracy of AF detection and treatment success rates, boosting adoption. Additionally, the growing preference for minimally invasive procedures, which offer faster recovery times and reduced complications, is further accelerating demand for electrophysiology devices in AF management.

Breakup by End User:

Hospitals
Diagnostic Centers
Others

Hospitals represents the leading market segment

The hospital segment is driven by the increasing prevalence of cardiovascular diseases, particularly arrhythmias, which require specialized electrophysiology procedures. Hospitals are equipped with advanced technology, such as 3D mapping and catheter ablation systems, enabling them to offer comprehensive cardiac care. The growing demand for minimally invasive procedures, which are often performed in hospital settings, further fuels this segment. Additionally, hospitals have skilled healthcare professionals capable of handling complex electrophysiology treatments, which boosts patient confidence in seeking care at these facilities. Rising healthcare expenditure, particularly in developed regions, allows hospitals to invest in cutting-edge electrophysiology devices, enhancing their capabilities.

Breakup by Region:

North America
- United States
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America leads the market, accounting for the largest electrophysiology devices market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for electrophysiology devices.

As per the electrophysiology devices market dynamics, the North America's regional market is driven by the increasing prevalence of cardiovascular diseases, particularly atrial fibrillation, among the aging population. Advanced healthcare infrastructure and widespread access to cutting-edge medical technologies support the adoption of electrophysiology devices across the region. Rising awareness of early diagnosis and treatment of heart conditions is boosting demand for these devices. Additionally, the growing preference for minimally invasive procedures has increased the use of catheter ablation and other electrophysiology tools. Continuous advancements in medical technology, such as 3D mapping systems and artificial intelligence (AI) integration, enhance the accuracy and outcomes of procedures, making them more attractive to both patients and healthcare providers, which is further driving the electrophysiology devices demand.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the electrophysiology devices industry include Biosense Webster Inc. (Johnson & Johnson), Biotronik SE & Co. KG, Boston Scientific Corporation, Cardiofocus Inc., Koninklijke Philips N.V., Medtronic Inc., MicroPort Scientific Corporation, Molecular Devices LLC (Danaher Corporation), Nihon Kohden Corporation, Siemens Healthcare GmbH, Stereotaxis Inc., etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Key players in the electrophysiology devices market are focusing on technological innovation and product development to stay competitive. They are investing in research and development (R&D) to create more advanced devices, such as next-generation catheter ablation systems and 3D mapping technologies, which offer improved precision and patient outcomes. Companies are also expanding their product portfolios by introducing new minimally invasive devices, making procedures less risky and more efficient. Strategic collaborations with hospitals and healthcare institutions are enabling key players to enhance their presence and strengthen their market share. In addition, many are adopting artificial intelligence and machine learning in their devices to enhance diagnostic capabilities and data interpretation, improving real-time decision-making during procedures.

Key Questions Answered in This Report

1.What was the size of the global electrophysiology devices market in 2024?
2.What is the expected growth rate of the global electrophysiology devices market during 2025-2033?
3.What are the key factors driving the global electrophysiology devices market?
4.What has been the impact of COVID-19 on the global electrophysiology devices market?
5.What is the breakup of the global electrophysiology devices market based on the product?
6.What is the breakup of the global electrophysiology devices market based on the indication?
7.What is the breakup of the global electrophysiology devices market based on the end user?
8.What are the key regions in the global electrophysiology devices market?
9.Who are the key players/companies in the global electrophysiology devices market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Electrophysiology Devices Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Treatment Devices
- 6.1.1 Market Trends
- 6.1.2 Major Types
  - 6.1.2.1 Implantable Cardioverter Defibrillators (ICDs)
  - 6.1.2.2 Automated External Defibrillators (AEDs)
  - 6.1.2.3 Pacemakers
  - 6.1.2.4 CRT-P
  - 6.1.2.5 CRT-D
  - 6.1.2.6 Catheters
  - 6.1.2.7 Others
- 6.1.3 Market Forecast
6.2 Diagnostic Devices
- 6.2.1 Market Trends
- 6.2.2 Major Types
  - 6.2.2.1 Holter Monitoring Devices
  - 6.2.2.2 Diagnostic Electrophysiology Catheters
  - 6.2.2.3 Electrocardiograph (ECG)
  - 6.2.2.4 EP Mapping & Imaging Systems
  - 6.2.2.5 Insertable Cardiac Monitors (ICM)
  - 6.2.2.6 Others
- 6.2.3 Market Forecast

7 Market Breakup by Indication

7.1 Atrial Fibrillation (AF)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Supraventricular Tachycardia
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Atrioventricular Nodal Re-entry Tachycardia (AVNRT)
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Wolff-Parkinson-White Syndrome (WPW)
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Bradycardia
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Other
- 7.6.1 Market Trends
- 7.6.2 Market Forecast

8 Market Breakup by End User

8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Diagnostic Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Biosense Webster Inc. (Johnson & Johnson)
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
- 14.3.2 Biotronik SE & Co. KG
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 SWOT Analysis
- 14.3.3 Boston Scientific Corporation
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 Cardiofocus Inc.
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
- 14.3.5 Koninklijke Philips N.V.
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 Medtronic Inc.
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 MicroPort Scientific Corporation
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
- 14.3.8 Molecular Devices LLC (Danaher Corporation)
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
- 14.3.9 Nihon Kohden Corporation
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis
- 14.3.10 Siemens Healthcare GmbH
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
- 14.3.11 Stereotaxis Inc.
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 Financials
  - 14.3.11.4 SWOT Analysis

電気生理学デバイス市場レポート：製品、適応症、エンドユーザー、地域別、2025年～2033年

Electrophysiology Devices Market Report by Product, Indication (Atrial Fibrillation, Supraventricular Tachycardia, Atrioventricular Nodal Re-entry Tachycardia, Wolff-Parkinson-White Syndrome, Bradycardia, and Other), End User, and Region 2025-2033

電気生理学デバイス市場動向：

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の電気生理学デバイス市場

第6章 市場内訳：製品別

第7章 市場内訳：適応症別

第8章 市場内訳：エンドユーザー別

第9章 市場内訳：地域別